Based on these observations, we hypothesize that GDE2 neuroprotective activity towards spinal motor neurons is diminished in the context of disease pathology, and that this impairment could contribute to disease progression in ALS. Here, GDPD5 is linked to amyotrophic lateral sclerosis.